Uliroid

Uliroid, featuring the active ingredient Ulipristal Acetate, is a highly effective oral medication designed for specific gynecological applications. This medication is primarily used for the management of uterine fibroids and emergency contraception, providing women with a reliable and clinically proven solution to address their reproductive health needs.

Indications and Uses
Ulipristal Acetate, the active compound in Uliroid, is a selective progesterone receptor modulator (SPRM). It is specifically indicated for:

1. Management of Uterine Fibroids: Uliroid helps reduce the size of fibroids, alleviate symptoms such as excessive menstrual bleeding, and improve overall quality of life.
2. Emergency Contraception: As an emergency contraceptive, Uliroid prevents ovulation and inhibits fertilization when taken within 120 hours (5 days) following unprotected intercourse or contraceptive failure.

Mechanism of Action
Ulipristal Acetate works by modulating progesterone receptors in the body, effectively altering the hormonal environment. For uterine fibroids, this leads to reduced fibroid size and symptomatic relief. As an emergency contraceptive, it delays ovulation, ensuring that fertilization does not occur.

Dosage and Administration

• For Uterine Fibroids: Typically prescribed as a daily oral tablet under a defined treatment cycle.
• For Emergency Contraception: A single oral dose of 30 mg within 120 hours of unprotected intercourse.

Benefits

• Provides targeted therapy for fibroid management.
• Offers a safe and effective option for emergency contraception.
• Convenient oral administration with minimal side effects when used as directed.

Precautions and Safety
Uliroid should be used under medical supervision, especially for long-term treatment. It is contraindicated in pregnant or breastfeeding women and those with liver impairment or hormone-sensitive cancers.

Conclusion
Uliroid is a versatile medication addressing two key women’s health concerns with proven efficacy and safety.